文献速递关节外科

氨甲环酸三种给药途径在初次单侧全膝关节置换术中的比较:前瞻性随机对照研究

Comparison of 3 Routes of Administration of Tranexamic Acid on Primary Unilateral Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study.
PubMed 文献 · J Arthroplasty · 2017-04-05

560例初次单侧全膝关节置换术患者随机分为静脉组、局部组、口服组和对照组,每组140例。三种氨甲环酸给药途径均较对照组显著减少术后48小时血红蛋白丢失、引流量、输血次数及输血费用,口服组氨甲环酸费用最低,血栓栓塞并发症、住院时间及伤口愈合无组间差异,但局部组出现伤口裂开和持续伤口渗液。作者推荐口服氨甲环酸。

要点

  • 静脉、局部、口服三种氨甲环酸途径均较对照组显著减少术后48小时血红蛋白丢失、引流量、输血次数及输血费用。
  • 口服组氨甲环酸费用显著低于局部组和静脉组。
  • 各组血栓栓塞并发症、术后住院时间及术后3周伤口愈合无差异,局部组出现伤口裂开和持续伤口渗液。

核心结论

  • 三种氨甲环酸给药途径均较对照组显著减少术后血红蛋白丢失、输血次数和输血费用,未观察到肺栓塞或感染。
  • 作者推荐口服氨甲环酸,因其与其他两种给药途径临床获益相似且氨甲环酸费用最低。

研究设计与样本

  • 前瞻性随机对照研究,共纳入560例初次单侧全膝关节置换术患者,随机分为4组,每组140例。
  • 静脉组接受2剂20 mg/kg静脉氨甲环酸;局部组接受3.0 g局部氨甲环酸;口服组接受2剂20 mg/kg口服氨甲环酸;对照组未给予氨甲环酸。
  • 主要结局包括术后48小时血红蛋白丢失和引流量、输血次数、输血费用和氨甲环酸费用、血栓栓塞并发症;次要结局为术后住院时间和术后3周伤口愈合。

主要发现

  • 静脉组、局部组和口服组的48小时血红蛋白丢失和引流量均显著少于对照组(P < .05)。
  • 对照组输血次数和输血费用显著多于其他3组(P < .05)。
  • 口服组氨甲环酸费用显著低于局部组和静脉组(P < .05)。
  • 各组血栓栓塞并发症、术后住院时间及术后3周伤口愈合无差异。
  • 局部组出现伤口裂开和持续伤口渗液。

关键数值与推荐

  • 静脉组:2剂20 mg/kg静脉氨甲环酸;局部组:3.0 g局部氨甲环酸;口服组:2剂20 mg/kg口服氨甲环酸;对照组:未给予氨甲环酸。
  • 48小时血红蛋白丢失和引流量:静脉组、局部组和口服组均显著少于对照组(P < .05)。
  • 输血次数和输血费用:对照组显著多于其他3组(P < .05)。
  • 氨甲环酸费用:口服组显著低于局部组和静脉组(P < .05)。

临床怎么用

  • 作者推荐口服氨甲环酸,因其与其他两种给药途径临床获益相似且氨甲环酸费用最低。

局限性

  • 局部组出现伤口裂开和持续伤口渗液。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The mode of administration for tranexamic acid (TXA) to significantly reduce the decrease in hemoglobin (Hb), number of transfusions, relevant costs, and side effects in patients undergoing primary unilateral total knee arthroplasty (TKA) has not been resolved. METHODS: A total of 560 patients undergoing primary unilateral TKA were randomized into 4 groups: intravenous group (140 patients receiving 2 doses of 20 mg/kg intravenous TXA), topical group (140 patients administered 3.0 g topical TXA), oral group (140 patients given 2 doses of 20 mg/kg oral TXA), and a control group (140 patients not given TXA). The primary outcomes included postoperative 48-hour Hb loss and drainage volume, number of transfusions, transfusion and TXA costs, and thromboembolic complications. Secondary outcomes were postoperative inpatient time and wound healing 3 weeks after TKA. RESULTS: Baseline data among the 4 groups were similar. The 48-hour Hb loss and drainage volume in the intravenous, topical, and oral groups were significantly less (P < .05) than those in the control group, and the latter had significantly more transfusions and transfusion costs than the other 3 groups (P < .05). The TXA cost was lowest in the oral group compared with that in the topical and intravenous groups (P < .05). No differences in thromboembolic complications, postoperative inpatient time, or wound healing were observed among the groups. However, wound dehiscence and continuous wound discharge occurred in the topical group. CONCLUSION: All the 3 modes of TXA administration significantly reduced postoperative Hb loss, the number of transfusions, and transfusion costs compared with those in the control group. No pulmonary embolism or infection was observed. Oral TXA is recommended because it provided a similar clinical benefit and resulted in the lowest TXA cost compared with the other 2 modes of TXA administration.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Yuan X, Li B, Wang Q, et al. Comparison of 3 Routes of Administration of Tranexamic Acid on Primary Unilateral Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study. J Arthroplasty. 2017. PMID: 28455182. doi:10.1016/j.arth.2017.03.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。